Neoadjuvant therapy is associated with altered composition of immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer Costa, A., Vayrynen, S., Chawla, A., Zhang, J., Vayrynen, J. P., Lau, M., Williams, H. L., Yuan, C., Morales-Oyarvide, V., Rubinson, D. A., Clancy, T. E., Brais, L. K., Reilly, E., Kozak, M. M., Linehan, D. C., Dunne, R. F., Chang, D. T., Hezel, A. F., Koong, A. C., Aguirre, A. J., Wolpin, B. M., Nowak, J. A. AMER ASSOC CANCER RESEARCH. 2020

View details for DOI 10.1158/1538-7445.PANCA20-PR-001

View details for Web of Science ID 000617413700080